Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease

This publication has 27 references indexed in Scilit:

• Striatal implantation of GDNF releasing biodegradable microspheres promotes recovery of motor function in a partial model of Parkinson's disease
  Biomaterials, 2004
• Localized striatal delivery of GDNF as a treatment for Parkinson disease
  Nature Neuroscience, 2004
• Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease
  Nature Medicine, 2003
• Aberrant Sprouting and Downregulation of Tyrosine Hydroxylase in Lesioned Nigrostriatal Dopamine Neurons Induced by Long-Lasting Overexpression of Glial Cell Line Derived Neurotrophic Factor in the Striatum by Lentiviral Gene Transfer
  Experimental Neurology, 2002
• Striatal neurochemical changes in transgenic models of Huntington's disease
  Journal of Neuroscience Research, 2002
• Induction of GDNF mRNA expression by melatonin in rat C6 glioma cells
  NeuroReport, 2002
• Melatonin protects against 6‐OHDA‐induced neurotoxicity in rats: a role for mitochondrial complex I activity
  The FASEB Journal, 2000
• Melatonin increases striatal dopaminergic function in 6-OHDA-lesioned rats
  NeuroReport, 1998
• Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra
  Brain Research, 1996
• Long‐Term Induction of Tyrosine Hydroxylase Expression: Compensatory Response to Partial Degeneration of the Dopaminergic Nigrostriatal System in the Rat Brain
  Journal of Neurochemistry, 1995